skip to content
  1. Home
  2. >
  3. Questions
  4. >
  5. BN: Hi, I know these 4 companies are quite different, but would be curious to learn your views on the pros and cons if each while looking at overall capital gains over the next 3+ years. [Brookfield Corporation Class A Limited Voting Shares]
You can view 2 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi, I know these 4 companies are quite different, but would be curious to learn your views on the pros and cons if each while looking at overall capital gains over the next 3+ years. Thanks for your service.
Asked by Vince on August 26, 2024
5i Research Answer:

As noted, these companies operate in different industries and are varying in size, but each name has its own risk and return profile.

BN: a high-quality management team coupled with an extensive real estate portfolio across various sectors. Emphasizes long-term growth through acquisitions and investing in high-quality assets. A strong long-term history of adding shareholder value. Downside risks include exposure to real estate, which can be highly sensitive to changes in interest rates. 

IFC: One of the leading property and casualty insurance companies in Canada. A high-quality, long-term compounder, with a decent dividend yield of 1.9%. Risks are competitive pressures from other insurance companies and higher claims expenses from unforeseen natural events.

PRL: High-growth, innovative, fintech name that primarily generates its revenue from the US. Continues to grow at a rapid pace, and its valuation is still reasonable. Downside risks include disruption from other fintech names, and competition from traditional banks as rates come down.

PAY: High-growth, small-cap name which trades at a cheap valuation. Benefits from growth in the 'gig economy', and continues to expand its services. Risks include dependence on key partnerships and any potential regulatory risks.